Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

OptimizeRx (OPRX) Tax Provisions (2023 - 2025)

OptimizeRx (OPRX) has disclosed Tax Provisions for 3 consecutive years, with $2.5 million as the latest value for Q4 2025.

  • Quarterly Tax Provisions rose 7.22% to $2.5 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.8 million through Dec 2025, up 150.62% year-over-year, with the annual reading at $1.8 million for FY2025, 150.76% up from the prior year.
  • Tax Provisions hit $2.5 million in Q4 2025 for OptimizeRx, up from $270000.0 in the prior quarter.
  • In the past five years, Tax Provisions ranged from a high of $2.5 million in Q4 2025 to a low of -$1.1 million in Q2 2024.
  • Historically, Tax Provisions has averaged $286111.1 across 3 years, with a median of $181000.0 in 2025.
  • Biggest five-year swings in Tax Provisions: tumbled 3396.97% in 2024 and later skyrocketed 133.05% in 2025.
  • Year by year, Tax Provisions stood at $33000.0 in 2023, then skyrocketed by 6827.27% to $2.3 million in 2024, then grew by 7.22% to $2.5 million in 2025.
  • Business Quant data shows Tax Provisions for OPRX at $2.5 million in Q4 2025, $270000.0 in Q3 2025, and $181000.0 in Q2 2025.